LPL Financial’s AbbVie ABBV Stock Holding History

LPL Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,000	Closed	-$210K	–	5549
2025 Q1	$210K	Sell	1,000 -14,200	-93%	-$2.76M	﹤0.01%	4842
2024 Q4	$2.7M	Buy	+15,200	New	+$2.79M	﹤0.01%	2591
2021 Q2	–	Sell	-2,700	Closed	-$292K	–	4220
2021 Q1	$292K	Buy	+2,700	New	+$289K	﹤0.01%	3480
2020 Q3	–	Sell	-2,500	Closed	-$245K	–	3546
2020 Q2	$245K	Buy	+2,500	New	+$220K	﹤0.01%	2983
2020 Q1	–	Sell	-2,700	Closed	-$239K	–	3203
2019 Q4	$239K	Buy	+2,700	New	+$224K	﹤0.01%	2958
2019 Q3	–	Sell	-15,000	Closed	-$1.09M	–	3287
2019 Q2	$1.09M	Buy	+15,000	New	+$1.18M	﹤0.01%	1660
2018 Q2	–	Sell	-8,100	Closed	-$767K	–	3207
2018 Q1	$767K	Sell	8,100 -500	-6%	-$54.9K	﹤0.01%	1809
2017 Q4	$832K	Buy	+8,600	New	+$811K	﹤0.01%	1669

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LPL Financial's ABBV Position: Q1 2026 in Review

LPL Financial increased its AbbVie (ABBV) stake by 2.4% in Q1 2026, buying an estimated $20.4M and bringing the position to 3,945,266 shares worth $858M. The position accounts for 0.23% of the portfolio, ranked #93.

LPL Financial first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $880M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

LPL Financial held 3,945,266 shares of AbbVie worth $858M as of Q1 2026.
LPL Financial bought 92,169 AbbVie shares in Q1 2026, an estimated $20.4M.
AbbVie made up 0.23% of LPL Financial's portfolio in Q1 2026, its #93 holding.
LPL Financial first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
LPL Financial's AbbVie position peaked at $880M in Q4 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.